RE:RE:CG Oncology NMIBC dataThe day CGOncology will be IPOed (it's presently private via 5 Financing Series totalling so far 200M$US), we'll know exactly how much we would be worth as they are also a one indication biotech so far and are in the exact same indication (BCG-unresponsive) as us.
So with a 200M$US private equity, CG Oncology is probably valued at 2B$US.
The advantage we have, is that we are in TLT @0.30$ on average. Once CG Oncology will be IPOed, their stock will probably start trading around 10$-15$US or around 1-2B$US in market valuation. So we already have a huge 20-30-45x advantage in being already in TLT. And we have whiners here!!! lollll
We just need to be patient again, for a few months, in the early months of 2023.